Chromosome and gene alterations in breast cancer as markers for diagnosis and prognosis as well as pathogenetic targets for therapy

American Journal of Medical Genetics - Seminars in Medical Genetics

Volumn 115, Issue 3, 2002, Pages 142-149

  Popescu, Nicholas C ^a   Zimonjic, Drazen B ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Amplification, deletion; Breast cancer; Chromosome rearrangements; DNA copy number imbalances; Gene expression profile; Genetic alterations; Proto oncogenes; Tumor suppressor genes

Indexed keywords

TUMOR MARKER; ACID ANHYDRIDE HYDROLASE; BRCA1 PROTEIN; BRCA2 PROTEIN; FRAGILE HISTIDINE TRIAD PROTEIN; TUMOR PROTEIN;

ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER GENETICS; CANCER RECURRENCE; CHROMOSOME ABERRATION; CHROMOSOME MUTATION; CYTOGENETICS; DISEASE ASSOCIATION; DISEASE MARKER; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCUS; GENE MUTATION; GENOME; HUMAN; MOLECULAR GENETICS; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; TREATMENT PLANNING; BREAST TUMOR; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; REVIEW;

ACID ANHYDRIDE HYDROLASES; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; CHROMOSOME ABERRATIONS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS;

EID: 0037202190     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajmg.10696     Document Type: Article

References (66)

1. Achuthan R, Bell SM, Roberts P, Leek JP, Horgan K, Markham AF, MacLennan KA, Speirs V. 2001. Genetic events during the transformation of a tamoxifen-sensitive human breast cancer cell line into a drug-resistant clone. Cancer Genet Cytogenet 130:166-172.
2. Adayinka A, Kytola S, Mertens F, Pandis N, Larsson C. 2000. Spectral karyotyping and chromosome banding studies of primary breast carcinomas and their lymph node metastases. Int J Mol Med 5:235-240.
3. Adeyinka A, Mertens F, Idvall I, Bondeson L, Ingvar C, Mitelman F, Pandis N. 1999. Different patterns of chromosomal imbalances in metastasising and non-metastasising primary breast carcinomas. Int J Cancer 84:370-375.
4. Albertson DG, Ylstra B, Segraves R, Collins C, Dairkee SH, Kowbel D, Kuo WL, Gray JW, Pinkel D. 2000. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nature Genet 25:144-146.
5. Anbazhagan R, Fujii H, Gabrielson E. 1998. Allelic loss of chromosomal arm 8p in breast cancer progression. Am J Pathol 152:815-819.
6. Barlund M, Monni O, Kononen J, Cornelison R, Torhorst J, Sauter G, Kallioniemi OP, Kallioniemi A. 2000. Multiple genes at 17q23 undergo amplification and overexpression in breast cancer. Cancer Res 60:5340-5344.
7. Bednarek AK, Keck-Waggoner CL, Daniel RL, Laflin KJ, Bergsagel PL, Kiguchi K, Brenner AJ, Aldaz CM. 2001. WWOX, the FRA16D gene, behaves as a suppressor of tumor growth. Cancer Res 61:8068-8073.
8. Bergthorsson JT, Johannsdottir J, Jonasdottir A, Eiriksdottir G, Egilsson V, Ingvarsson S, Barkardottir RB, Arason A. 1998. Chromosome imbalance at the 3p14 region in human breast tumours: High frequency in patients with inherited predisposition due to BRCA2. Eur J Cancer 34:142-147.
9. Collins C, Rommens JM, Kowbel D, Godfrey T, Tanner M, Hwang SI, Polikoff D, Nonet G, Cochran J, Myambo K, Jay KE, Froula J, Cloutier T, Kuo WL, Yaswen P, Dairkee S, Giovanola J, Hutchinson GB, Isola J, Kallioniemi OP, Palazzolo M, Martin C, Ericsson C, Pinkel D, Albertson D, Li W, Gray JW 1998. Positional cloning of ZNF217 and NABC1: Genes amplified at 20q13.2 and overexpressed in breast carcinoma. Proc Natl Acad Sci USA 95:8703-8708.
10. Collins C, Volik S, Kowbel D, Ginzinger D, Yistra B, Cloutier T, Hawkins T, Predki P, Martin C, Wernick M, Kuo W-L, Alberts A, Gray JW 2001. Comprehensive genome sequence analysis of a breast cancer amplicon. Genome Res 11:1034-1042.
11. Courtay-Cahen C, Morris JS, Edwards PAW 2000. Chromosome translocations in breast cancer with breakpoints at 8p12. Genomics 66:15-25.
12. Croce CM. 2001. How can we prevent cancer? Proc Natl Acad Sci USA 98:10986-10988.
13. Daigo Y, Chin S-F, Gorringe KL, Bobrow LG, Ponder BAJ, Pharoah PDP, Caldas C. 2001. Degenerate oligonucleotide-primed polymerase chain reaction-based array comparative genomic hybridization for extensive amplicon profiling of breast cancers: A new approach for the molecular analysis of paraffin-embedded cancer tissue. Am J Pathol 158:1623-1631.
14. Davidson JM, Gorringe KL, Chin SF, Orsetti B, Besret C, Courtay-Cahen C, Roberts I, Theillet C, Caldas C, Edwards PAW. 2000. Molecular cytogenetic analysis of breast cancer cell lines. Br J Cancer 83:1309-1317.
15. Elenbaas B, Spirio L, Koerner F, Fleming MD, Zimonjic DB, Donaher JL, Popescu NC, Hahn WC, Weinberg RA. 2001. Human breast cancer cells generated by oncogenic transformation of primary epithelial cells. Genes Dev 15:50-65.
16. Finlin BS, Gau CL, Murphy GA, Shao HP, Kimel T, Seitz RS, Chiu YF, Botstein D, Brown PO, Tamanoi F, Andres DA, Perou CM. 2001. RERG is a novel ras-related, estrogen-regulated and growth-inhibitory gene in breast cancer. J Biol Chem 276:42259-42267.
17. Forozan F, Mahlamaki EH, Monni O, Chen Y, Veldman R, Jiang Y, Gooden GC, Ethier SP, Kallioniemi A, Kallioniemi OR 2000. Comparative genomic hybridization analysis of 38 breast cancer cell lines: A basis for interpreting complementary DNA microarray data. Cancer Res 60:4519-4525.
18. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, Lender ES. 1999. Molecular classification of cancer: Class discovery and class prediction by gene expresssion monitoring. Science 286:531-537.
19. Gruvberger S, Ringner M, Chen YD, Panavally S, Saal LH, Borg A, Ferno M, Peterson C, Meltzer PS. 2001. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res 61:5979-5984.
20. Hedenfalk I, Duggan D, Chen YD, Radmacher M, Bittner M, Simon R, Meltzer P, Gusterson B, Esteller M, Kallioniemi OP, Wilfond B, Borg A, Trent J. 2001. Geneexpression profiles in hereditary breast cancer. N Engl J Med 344:539-548.
21. Heiskanen M, Kononen J, Barlund M, Torhorst J, Sauter G, Kallioniemi A, Kallioniemi O. 2001. cDNA and tissue microarray analyses implicate FGFR2 amplification in a small subset of breast tumors. Anal Cell Pathol 22:229-234.
22. Houghton RL, Dillion DC, Molesh DA, Zehentner BK, Xu JC, Jiang J, Schmidt C, Frudakis A, Repasky E, Maltez A, Nolasco M, Badaro R, Zhang XQ, Roche PC, Persing DH, Reed SG. 2001. Transcriptional complementarity in breast cancer: Application to detection of circulating tumor cells. Mol Diagn 6:79-91.
23. Huebner K, Hadaczek P, Siprashvili Z, Druck T, Croce CM. 1997. The FHIT gene, a multiple tumor suppressor gene encompassing the carcinogen sensitive chromosome fragile site, FKA3B. Biochim Biophys Acta 1332:M65-70.
24. Ishii H, Vecchione A, Murakumo Y, Baldassarre G, Numata S, Trapasso F, Alder H, Baffa R, Croce CM. 2001. FEZ1/LZTS1 gene at 8p22 suppresses cancer cell growth and regulates mitosis. Proc Natl Acad Sci USA 98:10374-10379.
25. Jain AN, Chin K, Borresen-Dale A-L, Erikstein BK, Lonning PE, Kaaresen R, Gray JW. 2001. Quantitative analysis of chromosomal CGH in human breast tumors associates copy number abnormalities with p53 status and patient survival. Proc Natl Acad Sci USA 98:7952-7957.
26. Jhaveri MS, Wagner C, Trepel JB. 2001. Impact of extracellular folate levels on global gene expression. Mol Pharmacol 60:1288-1295.
27. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D. 1992a. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818-821.
28. Kallioniemi OP, Kallioniemi A, Kurisu W, Thor A, Chen LC, Smith HS, Waldman FM, Pinkel D, Gray JW. 1992b. Erbb2 amplification in breast cancer analyzed by fluorescence in situ hybridization. Proc Natl Acad Sci USA 89:5321-5325.
29. Kauraniemi P, Barlund M, Monni O, Kallioniemi A. 2001. New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays. Cancer Res 61:8235-8240.
30. Klus GT, Rokaeus N, Bittne ML, Chen YD, Korz DM, Sukumar S, Schick A, Szallasi Z. 2001. Down-regulation of the desmosomal cadherin desmocollin 3 in human breast cancer. Int J Oncol 19:169-174.
31. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP. 1998. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nature Med 4:844-847.
32. Kraus MH, Popescu NC, Amsbaugh SC, King CR. 1987. Overexpression of the Egf receptor-related proto-oncogene Erbb-2 in human mammary tumor cell lines by different molecular mechanisms. EMBO J 6:605-610.
33. Kudoh K, Ramanna M, Ravatn R, Elkahloun AG, Bittner ML, Meltzer PS, Trent JM, Dalton WS, Chin KV. 2000. Monitoring the expression profiles of doxorubicin-induced and doxorubicin-resistant cancer cells by cDNA microarray. Cancer Res 60:4161-4166.
34. Kytola S, Rumukainen J, Nordgren A, Karhu R, Farnebo F, Isola J, Larsson C. 2000. Chromosomal alterations in 15 breast cancer cell lines by comparative genomic hybridization and spectral karyotyping. Genes Chromosom Cancer 28:308-317.
35. Lu Y-J, Williamson D, Clark J, Wang R, Tiffin N, Skelton L, Gordon T, Williams R, Allan B, Jackman A, Cooper C, Pritchard-Jones K, Shipley J. 2001. Comparative expressed sequence hybridization to chromosomes for tumor classification and identification of genomic regions of differential gene expression. Proc Natl Acad Sci USA 98:9197-9202.
36. Lundin C, Mertens F. 1998. Cytogenetics of benign breast lesions. Breast Cancer Res Treat 51:1-15.
37. Micci F, Teixeira MR, Heim S. 2001. Complete cytogenetic characterization of the human breast cancer cell line MA 11 combining G-banding, comparative genomic hybridization, multicolor fluorescence in situ hybridization, RxFISH, and chromosomespecific painting. Cancer Genet Cytogenet 131:25-30.
38. Mitelman F, Mertens F, Johansson AB. 1997. A breakpoint map of reccurent chromosomal rearrangements in human neoplasia. Nature Genet 15:417-474.
39. Monni O, Barlund M, Mousses S, Kononen J, Sauter G, Heiskanen M, Paavola P, Avela K, Chen Y, Bittner ML, Kallioniemi A. 2001. Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer. Proc Natl Acad Sci USA 98:5711-5716.
40. Morris JS, Carter NP, Ferguson-Smith MA, Edwards PAW. 1997. Cytogenetic analysis of three breast carcinoma cell lines using reverse chromosome painting. Genes Chromosom Cancer 20:120-139.
41. Mullan PB, McWilliams S, Quinn J, Andrews H, Gilmore P, McCabe N, McKenna S, Harkin DP. 2001. Uncovering BRCA1-regulated signalling pathways by microarray-based expression profiling. Biochem Soc Trans 29:678-683.
42. Newsham IF. 1998. The long and short of chromosome 11 in breast cancer. Am J Pathol 153:5-9.
43. Nowell PC, Croce CM. 1986. Chromosomes, genes and cancer. Am J Pathol 125:7-16.
44. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffreyk SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge EI, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D. 2000. Molecular portraits of human breast tumours. Nature 406:747-752.
45. Pinkel D, Straume T, Gray JW. 1986. Cytogenetic analysis using quantitative, high sensitivity, fluorescence hybridization. Proc Natl Acad Sci USA 83:2934-2938.
46. Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Kowbel D, Collins C, Kuo WL, Chen C, Zhai Y, Dairkee SH, Ljung BM, Gray JW, Albertson DG. 1998. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nature Genet 20:207-211.
47. Pollack JR, Perou CM, Alizadeh AA, Eisen MB, Pergamenschikov A, Williams CF, Jeffrey SS, Botstein D, Brown PO. 1999. Genomewide analysis of DNA copy number changes using cDNA microarrays. Nature Genet 23:41-46.
48. Reddy DE, Sandhu AK, DeRiel JK, Athwal RS, Kaur GP. 1999. Identification of a gene at 16q24.3 that restores cellular senescence in immortal mammary tumor cells. Oncogene 18:5100-5107.
49. Reddy DE, Keck CL, Popescu N, Athwal RS, Kaur GP. 2000. Identification of a YAC from 16q24 carrying a senescence gene for breast cancer cells. Oncogene 19:217-222.
50. Sandberg AA, Chen Z. 1995. Cancer cytogenetics and molecular genetics: Clinical implications (Review). Int J Oncol 7:1241-1251.
51. Savelyeva L, Claas A, Matzner I, Schlag P, Hofmann W, Scherneck S, Weber B, Schwab M. 2001. Constitutional genomic instability with inversions, duplications, and amplifications in 9p23-24 in BRCA2 mutation carriers. Cancer Res 61:5179-5185.
52. Schena M, Shalon D, Davis RW, Brown PO. 1995. Quantitative monitoring of gene expression pattern with complementary DNA microarray. Science 270:694-698.
53. Schröck E. du Manoir S, Veldman T, Schoell B, Wienberg J, Ferguson-Smith MA, Ning Y, Ledbetter DH, Bar-Am I, Soenksen D, Garini Y, Ried T. 1996. Multicolor spectral karyotyping of human chromosomes. Science 273:494-497.
54. Schuuring E. 1995. The involvement of the chromosome 11q13 region in human malignancies: Cyclin D1 and EMS1 are two new candidate oncogenes: A review. Gene 159:83-96.
55. Simon R, Nocito A, Hubscher T, Bucher C, Torhorst J, Schraml P, Bubendorf L, Mihatsch MM, Holger M, Wilber K, Schötzau A, Konomen J, Sauter G. 2001. Patterns of HER-2/neu amplification and over-expression in primary and metastatic breast cancer. J Natl Cancer Inst 93:1141-1146.
56. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. 1987. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235:177-182.
57. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Lonning PE, Borresen-Dale AL. 2001. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98:10869-10874.
58. Speicher MR, Ballard SG, Ward DC. 1996. Karyotyping human chromosomes by combinatorial multi-fluor FISH. Nature Genet 368-375.
59. Tirkkonen MTM, Karhu R, Kallioniemi A, Isola J, Kallioniemi OP. 1998. Molecular cytogenetics of primary breast cancer by CGH. Genes Chromosom Cancer 21:177-184.
60. Unger MA, Rishi M, Clemmer VB, Hartman JL, Keiper EA, Greshock JD, Chodosh LA, Liebman MN, Weber BL. 2001. Characterization of adjacent breast tumors using oligonucleotide microarrays. Breast Cancer Res 3:336.
61. Watson MA, Darrow C, Zimonjic DB, Popescu NC, Fleming TP. 1998. Structure and transcriptional regulation of the human mammaglobin gene, a breast cancer associated member of the uteroglobin gene family localized to chromosome 11q13. Oncogene 16:817-824.
62. West M, Blanchette C, Dressman H, Huang E, Ishida S, Spang R, Zuzan H, Olson JA, Marks JR, Nevins JR. 2001. Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci USA 98:11462-11467.
63. Ye Q, Hu Y-F, Zhong H, Nye AC, Belmont AS, Li R. 2001. BRCA1-induced largescale chromatin unfolding and allelespecific effects of cancer-predisposing mutation. J Cell Biol 155:911-921.
64. Yu Q, Geng Y, Sicinski P. 2001. Specific protection against breast cancers by cyclin D1 ablation. Nature 411:1017-1021.
65. Yuan B-Z, Miller MJ, Keck CL, Zimonjic D, Thorgeirsson SS, Popescu NC. 1998. Cloning, characterization and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homogous to rat RhoGAP. Cancer Res 58:2196-2199.
66. Zimonjic DB, Keck-Waggoner CL, Yuan B-Z, Kraus MH, Popescu NC. 2000. Profile of genetic alterations and tumorigencity of human breast cancer cells. Intl J Oncol 16:221-230.